Overview

TD-6450 SAD and MAD in Healthy Subjects

Status:
Completed

Trial end date:
2014-09-01

Target enrollment:

Participant gender:

Summary

This study consists of two parts, Parts A and B. Part A is a single ascending dose (SAD) study in healthy subjects. Part B is a multiple ascending dose (MAD) study in healthy subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Theravance Biopharma
Theravance Biopharma R & D, Inc.